Deprince Race & Zollo Inc Merck & Co., Inc. Transaction History

Deprince Race & Zollo Inc

$4.59 Billion
Q1 2024

A detailed history of Deprince Race & Zollo Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Deprince Race & Zollo Inc holds 292,548 shares of MRK stock, worth $36.2 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares

292,548

Previous 295,660 1.05%

Holding current value

$36.2 Million

Previous $32.2 Million 19.76%

% of portfolio

0.84%

Previous 0.74%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $352,402 - $410,628	-3,112 Reduced 1.05%	292,548 $38.6 Million
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $2.64 Million - $2.87 Million	26,366 Added 9.79%	295,660 $32.2 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $827,820 - $919,327	8,041 Added 3.08%	269,294 $27.7 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $3.88 Million - $4.23 Million	-35,754 Reduced 12.04%	261,253 $30.1 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $3.65 Million - $4.07 Million	-35,467 Reduced 10.67%	297,007 $31.6 Million

Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $1.38 Million - $1.78 Million	-15,836 Reduced 4.55%	332,474 $36.9 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $135,839 - $152,600	-1,607 Reduced 0.46%	348,310 $30 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $10.2 Million - $11.6 Million	-122,661 Reduced 25.96%	349,917 $31.9 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $2.45 Million - $2.75 Million	33,381 Added 7.6%	472,578 $38.8 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $2.93 Million - $3.67 Million	40,577 Added 10.18%	439,197 $33.7 Million
Q3 2021 Nov 17, 2021	SELL	$71.68 - $78.83 $500,039 - $549,918	-6,976 Reduced 1.72%	398,620 $29.9 Million
Q2 2021 Aug 12, 2021	BUY	$70.31 - $77.77 $1.28 Million - $1.42 Million	18,207 Added 4.7%	405,596 $31.5 Million
Q1 2021 May 18, 2021	BUY	$68.86 - $81.11 $9.09 Million - $10.7 Million	132,030 Added 51.7%	387,389 $29.9 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $4.11 Million - $4.56 Million	57,231 Added 28.89%	255,359 $20.9 Million
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $69,740 - $79,051	953 Added 0.48%	198,128 $16.4 Million
Q2 2020 Aug 11, 2020	SELL	$70.42 - $80.13 $1.23 Million - $1.4 Million	-17,471 Reduced 8.14%	197,175 $15.2 Million
Q1 2020 Apr 13, 2020	BUY	$63.36 - $87.82 $1.26 Million - $1.75 Million	19,895 Added 10.22%	214,646 $16.5 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $1.37 Million - $1.55 Million	-17,692 Reduced 8.33%	194,751 $17.7 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $1.49 Million - $1.62 Million	-19,555 Reduced 8.43%	212,443 $17.9 Million
Q2 2019 Aug 13, 2019	SELL	$69.84 - $81.59 $4.73 Million - $5.52 Million	-67,676 Reduced 22.58%	231,998 $19.5 Million
Q1 2019 Apr 18, 2019	SELL	$69.58 - $79.36 $6.79 Million - $7.74 Million	-97,579 Reduced 24.56%	299,674 $0
Q4 2018 Jan 30, 2019	SELL	$65.24 - $75.71 $12.1 Million - $14.1 Million	-185,853 Reduced 31.87%	397,253 $30.4 Million
Q3 2018 Oct 15, 2018	SELL	$57.69 - $67.84 $5.63 Million - $6.62 Million	-97,655 Reduced 14.34%	583,106 $41.4 Million
Q2 2018 Jul 17, 2018	SELL	$50.83 - $59.72 $1.45 Million - $1.7 Million	-28,460 Reduced 4.01%	680,761 $41.3 Million
Q1 2018 Apr 18, 2018	BUY	$50.96 - $59.23 $1.26 Million - $1.46 Million	24,660 Added 3.6%	709,221 $38.6 Million
Q4 2017 Jan 26, 2018	BUY	$51.62 - $61.64 $1.65 Million - $1.97 Million	31,996 Added 4.9%	684,561 $38.5 Million
Q3 2017 Nov 07, 2017	BUY	$58.67 - $63.13 $38.3 Million - $41.2 Million	652,565	652,565 $41.8 Million

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deprince Race & Zollo Inc, based on Form 13F filings with the SEC.

News

Stay updated on Deprince Race & Zollo Inc with notifications on news.

Account

Deprince Race & Zollo Inc Merck & Co., Inc. Transaction History